Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

ConditionsChronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Nonmalignant Neoplasm

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-120

SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Acute myeloid leukemia

Acute lymphoblastic leukemia

Chronic myelogenous leukemia

Chronic lymphoid leukemia

Disqualifiers

None

Trial population

Hematologic malignancies

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

biologic sample preservation procedure
Other intervention
All samples collected during routine clinical care.
cytology specimen collection procedure
Other intervention
All Samples collected during routine clinical care.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Tissue, blood, and body fluid samples collection for ongoing diagnostic, prognostic, or immune-monitoring studies

Time frame

30 years

Development of a centralized, quality-controlled, quality-assured facility for the procurement, processing, storage, and distribution of normal and malignant tissue specimens and corresponding blood specimens

Time frame

30 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

UNC Lineberger Comprehensive Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov

Apply now